This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San DiegoLive In-Person Event: December 14 - 17, 2025

Dr. Jennifer Sun, PhD
Global Director of Field Application Scientists at DPBIO
Speaker

Profile

Dr. Jennifer Sun is an innovation leader, entrepreneur, and scientist with over 20 years of experience in microfluidics, biomaterials, organ-on-a-chip technologies, and advanced manufacturing. She currently serves as the Global Director of Field Application Scientists at DPBIO, where she leads the implementation of droplet microfluidics platforms for antibody discovery and single-cell analysis. Dr. Sun holds a joint Ph.D. from Harvard University and Fudan University and has held leadership roles at Allegro 3D and BMF Precision, driving R&D, product development, and commercialization of innovative biomedical technologies. Notably, her contributions at Allegro 3D played a key role in positioning the company for its successful merger with Cellink and acquisition by BICO, a leader in bioconvergence technologies. An accomplished inventor and published researcher, Dr. Sun combines deep scientific expertise with entrepreneurial insight to translate innovations into impactful real-world applications. At the conference, she will present how DPBIO's High-Throughput Droplet Sorting Technology accelerates antibody discovery and development.

Agenda Sessions

  • Empowering Single B Cell Monoclonal Antibody Discovery: High-Throughput Plasma B Cell Screening with DPBIO’s CytoSpark®

    4:10pm